Governments are playing a bigger role in cell and gene therapy manufacturing
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s...
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s...
The results investigated the efficacy and safety of cabotegravir/rilpivirine, the company’s once-monthly injection for treating...
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
John Shillingford, Clinical Operations Director, Orsus Medical, describes the inherent challenges facing small- to mid-sized...
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded...
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on...
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has...
Clinical Trials Arena highlights the best articles from 2018